Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 9.03309717 |
2 | polyketide metabolic process (GO:0030638) | 9.03309717 |
3 | doxorubicin metabolic process (GO:0044598) | 9.03309717 |
4 | maintenance of protein location in nucleus (GO:0051457) | 6.45529186 |
5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.75758651 |
6 | negative regulation of cell killing (GO:0031342) | 5.74840123 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.74840123 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69926013 |
9 | somite rostral/caudal axis specification (GO:0032525) | 5.63682314 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.59007572 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.56534837 |
12 | regulation of response to osmotic stress (GO:0047484) | 5.55906172 |
13 | regulation of cilium movement (GO:0003352) | 5.53771560 |
14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45856856 |
15 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.43071229 |
16 | synaptic vesicle maturation (GO:0016188) | 5.41320774 |
17 | histone H4-K5 acetylation (GO:0043981) | 5.29112234 |
18 | histone H4-K8 acetylation (GO:0043982) | 5.29112234 |
19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.16669473 |
20 | negative regulation of epidermis development (GO:0045683) | 5.13024881 |
21 | proline transport (GO:0015824) | 5.10995269 |
22 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.08885403 |
23 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.02747544 |
24 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.93860442 |
25 | histone H4-K12 acetylation (GO:0043983) | 4.93707634 |
26 | negative regulation of telomerase activity (GO:0051974) | 4.66639577 |
27 | muscle organ morphogenesis (GO:0048644) | 4.62586641 |
28 | response to dietary excess (GO:0002021) | 4.60497818 |
29 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.54071232 |
30 | neutrophil activation involved in immune response (GO:0002283) | 4.48010031 |
31 | protein polyglutamylation (GO:0018095) | 4.43681111 |
32 | phenol-containing compound catabolic process (GO:0019336) | 4.41277750 |
33 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.36847388 |
34 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.36437286 |
35 | cytidine metabolic process (GO:0046087) | 4.34738796 |
36 | cytidine catabolic process (GO:0006216) | 4.34738796 |
37 | cytidine deamination (GO:0009972) | 4.34738796 |
38 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.30765005 |
39 | rRNA transcription (GO:0009303) | 4.29077081 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29063828 |
41 | positive thymic T cell selection (GO:0045059) | 4.27899969 |
42 | protein localization to kinetochore (GO:0034501) | 4.25072641 |
43 | mitochondrion distribution (GO:0048311) | 4.24989115 |
44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.23502784 |
45 | microtubule severing (GO:0051013) | 4.23111289 |
46 | tachykinin receptor signaling pathway (GO:0007217) | 4.21855648 |
47 | histone H4-K16 acetylation (GO:0043984) | 4.21058869 |
48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.14858257 |
49 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13500350 |
50 | detection of bacterium (GO:0016045) | 4.13442706 |
51 | B cell receptor signaling pathway (GO:0050853) | 4.12353652 |
52 | detection of other organism (GO:0098543) | 4.09128373 |
53 | positive regulation by symbiont of host defense response (GO:0052509) | 4.05555177 |
54 | modulation by symbiont of host defense response (GO:0052031) | 4.05555177 |
55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.05555177 |
56 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.05555177 |
57 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.05555177 |
58 | modulation by symbiont of host immune response (GO:0052553) | 4.05555177 |
59 | glutamate secretion (GO:0014047) | 4.02948579 |
60 | positive regulation of B cell differentiation (GO:0045579) | 3.98592402 |
61 | negative thymic T cell selection (GO:0045060) | 3.97582649 |
62 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.96633793 |
63 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.96575508 |
64 | tolerance induction (GO:0002507) | 3.94983432 |
65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93798314 |
66 | leukocyte aggregation (GO:0070486) | 3.93633301 |
67 | mannose metabolic process (GO:0006013) | 3.89773222 |
68 | interferon-gamma production (GO:0032609) | 3.85892492 |
69 | heterochromatin organization (GO:0070828) | 3.85816981 |
70 | thymic T cell selection (GO:0045061) | 3.85132960 |
71 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.82264738 |
72 | negative T cell selection (GO:0043383) | 3.82008739 |
73 | hormone catabolic process (GO:0042447) | 3.79508522 |
74 | mitotic sister chromatid segregation (GO:0000070) | 3.76264630 |
75 | response to peptidoglycan (GO:0032494) | 3.76186741 |
76 | regulation of mast cell degranulation (GO:0043304) | 3.76011803 |
77 | regulation of B cell differentiation (GO:0045577) | 3.72760545 |
78 | T cell selection (GO:0045058) | 3.71552775 |
79 | response to muramyl dipeptide (GO:0032495) | 3.64694743 |
80 | ventricular system development (GO:0021591) | 3.59774756 |
81 | notochord development (GO:0030903) | 3.58103830 |
82 | maintenance of protein localization in organelle (GO:0072595) | 3.56116622 |
83 | regulation of leukocyte degranulation (GO:0043300) | 3.55684478 |
84 | positive T cell selection (GO:0043368) | 3.53401422 |
85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52863637 |
86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50652499 |
87 | regulation of tolerance induction (GO:0002643) | 3.49600579 |
88 | protein localization to cilium (GO:0061512) | 3.48467809 |
89 | regulation of microtubule-based movement (GO:0060632) | 3.47434371 |
90 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47355702 |
91 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.46859971 |
92 | cellular extravasation (GO:0045123) | 3.42774572 |
93 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41194313 |
94 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.41133666 |
95 | positive regulation of granulocyte differentiation (GO:0030854) | 3.38292463 |
96 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38098010 |
97 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34926202 |
98 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.33543894 |
99 | neutrophil activation (GO:0042119) | 3.33308057 |
100 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.31583987 |
101 | negative regulation of telomere maintenance (GO:0032205) | 3.30380946 |
102 | immunoglobulin mediated immune response (GO:0016064) | 3.28158910 |
103 | transepithelial transport (GO:0070633) | 3.27117958 |
104 | macrophage activation involved in immune response (GO:0002281) | 3.26274971 |
105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.23759892 |
106 | nucleoside transmembrane transport (GO:1901642) | 3.22083052 |
107 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.21823505 |
108 | positive regulation of digestive system process (GO:0060456) | 3.21108796 |
109 | hypotonic response (GO:0006971) | 3.20147133 |
110 | primitive streak formation (GO:0090009) | 3.19453300 |
111 | positive regulation of tolerance induction (GO:0002645) | 3.18322422 |
112 | detection of temperature stimulus (GO:0016048) | 3.16713094 |
113 | locomotory exploration behavior (GO:0035641) | 3.15839668 |
114 | rRNA methylation (GO:0031167) | 3.14475065 |
115 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.14094314 |
116 | cellular modified amino acid catabolic process (GO:0042219) | 3.13196563 |
117 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.12609081 |
118 | respiratory burst (GO:0045730) | 3.12208022 |
119 | pre-miRNA processing (GO:0031054) | 3.11893477 |
120 | chromatin assembly (GO:0031497) | 3.10154957 |
121 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.09267241 |
122 | coenzyme catabolic process (GO:0009109) | 3.09107275 |
123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08080143 |
124 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07882065 |
125 | synaptic vesicle exocytosis (GO:0016079) | 3.05813113 |
126 | quinone metabolic process (GO:1901661) | 3.05755378 |
127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05528436 |
128 | detection of external biotic stimulus (GO:0098581) | 3.03564757 |
129 | regulation of telomere maintenance (GO:0032204) | 3.03377532 |
130 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.02442152 |
131 | sister chromatid segregation (GO:0000819) | 3.02266258 |
132 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.01772360 |
133 | cardiovascular system development (GO:0072358) | 3.01331723 |
134 | response to interleukin-15 (GO:0070672) | 3.00804217 |
135 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00098179 |
136 | positive regulation of Rap GTPase activity (GO:0032854) | 2.99594981 |
137 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.99147011 |
138 | T cell migration (GO:0072678) | 2.97120354 |
139 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.96871455 |
140 | regulation of Rap GTPase activity (GO:0032317) | 2.96656305 |
141 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.95631632 |
142 | positive regulation of protein deacetylation (GO:0090312) | 2.94870108 |
143 | granulocyte activation (GO:0036230) | 2.94473293 |
144 | positive regulation of synapse maturation (GO:0090129) | 2.93879624 |
145 | regulation of regulated secretory pathway (GO:1903305) | 2.91948489 |
146 | regulation of necroptotic process (GO:0060544) | 2.91236724 |
147 | regulation of telomerase activity (GO:0051972) | 2.90743190 |
148 | receptor recycling (GO:0001881) | 2.90457108 |
149 | negative regulation of interleukin-6 production (GO:0032715) | 2.90333788 |
150 | arachidonic acid secretion (GO:0050482) | 2.90262287 |
151 | icosanoid secretion (GO:0032309) | 2.90262287 |
152 | germinal center formation (GO:0002467) | 2.89961623 |
153 | negative regulation of phagocytosis (GO:0050765) | 2.89853807 |
154 | regulation of T cell tolerance induction (GO:0002664) | 2.89610026 |
155 | protein localization to chromosome, centromeric region (GO:0071459) | 2.88926115 |
156 | adaptation of signaling pathway (GO:0023058) | 2.87980515 |
157 | vocalization behavior (GO:0071625) | 2.87249640 |
158 | response to laminar fluid shear stress (GO:0034616) | 2.85737065 |
159 | apoptotic DNA fragmentation (GO:0006309) | 2.84524924 |
160 | negative regulation of interleukin-8 production (GO:0032717) | 2.83058896 |
161 | retinoic acid receptor signaling pathway (GO:0048384) | 2.82023204 |
162 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.81165939 |
163 | Peyers patch development (GO:0048541) | 2.80694821 |
164 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80694821 |
165 | ovulation cycle (GO:0042698) | 2.77664585 |
166 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77374397 |
167 | response to type I interferon (GO:0034340) | 2.75993034 |
168 | type I interferon signaling pathway (GO:0060337) | 2.75240626 |
169 | cellular response to type I interferon (GO:0071357) | 2.75240626 |
170 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.75059277 |
171 | melanosome transport (GO:0032402) | 2.74866530 |
172 | myeloid cell activation involved in immune response (GO:0002275) | 2.74739665 |
173 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74387164 |
174 | positive regulation of macrophage cytokine production (GO:0060907) | 2.73749701 |
175 | positive regulation of histone deacetylation (GO:0031065) | 2.73402978 |
176 | neurotransmitter secretion (GO:0007269) | 2.72836464 |
177 | negative regulation of innate immune response (GO:0045824) | 2.72196204 |
178 | regulation of mast cell activation (GO:0033003) | 2.70390354 |
179 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69872657 |
180 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67524144 |
181 | regulation of granulocyte differentiation (GO:0030852) | 2.67424313 |
182 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.66990813 |
183 | defense response to protozoan (GO:0042832) | 2.66975409 |
184 | detection of biotic stimulus (GO:0009595) | 2.65833730 |
185 | positive regulation of mast cell activation (GO:0033005) | 2.65326427 |
186 | actin filament polymerization (GO:0030041) | 2.65303082 |
187 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.65190381 |
188 | phospholipid scrambling (GO:0017121) | 2.64952921 |
189 | T cell homeostasis (GO:0043029) | 2.63207735 |
190 | neutrophil mediated immunity (GO:0002446) | 2.63203013 |
191 | leukocyte degranulation (GO:0043299) | 2.62907787 |
192 | axonemal dynein complex assembly (GO:0070286) | 2.62459571 |
193 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60828008 |
194 | megakaryocyte development (GO:0035855) | 2.59714522 |
195 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.58556248 |
196 | histone H3-K36 demethylation (GO:0070544) | 2.58428476 |
197 | negative regulation of type 2 immune response (GO:0002829) | 2.58300478 |
198 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57688916 |
199 | response to host immune response (GO:0052572) | 2.57688916 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.42008465 |
2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.96162386 |
3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.96162386 |
4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.96162386 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.75736457 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57301901 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.53637448 |
8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.16702458 |
9 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.86593007 |
10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.83505925 |
11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82927683 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79315093 |
13 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.68705478 |
14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.49702975 |
15 | MAF_26560356_Chip-Seq_TH1_Human | 2.49304789 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37692938 |
17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.37559922 |
18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.36844349 |
19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.35158063 |
20 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.31652024 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29833733 |
22 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.25854137 |
23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25136680 |
24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24769251 |
25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20826760 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19605639 |
27 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.19422300 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15855315 |
29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12599604 |
30 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.10919774 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.10754997 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07202292 |
33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.07129859 |
34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06518698 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06297556 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04285829 |
37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.03980009 |
38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.03538074 |
39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01564811 |
40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99633261 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.99423522 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98393246 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.97856401 |
44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96925879 |
45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95340499 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.90401431 |
47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89556849 |
48 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.88881517 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83632726 |
50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82733328 |
51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.80006396 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79311288 |
53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79226585 |
54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78036926 |
55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.77630279 |
56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74561836 |
57 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.69341194 |
58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.68921240 |
59 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68667689 |
60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65899073 |
61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65514262 |
62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65137216 |
63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.64464590 |
64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.61093789 |
65 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60634615 |
66 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.60616795 |
67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.59444836 |
68 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.58767122 |
69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57926269 |
70 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.57811030 |
71 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57500333 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57370654 |
73 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.56833530 |
74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56483206 |
75 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.55301308 |
76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53469879 |
77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53403508 |
78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53263314 |
79 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.52902022 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52240956 |
81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51961022 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51894381 |
83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.50701037 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49081661 |
85 | P68_20966046_ChIP-Seq_HELA_Human | 1.48278898 |
86 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47353875 |
87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47183304 |
88 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46914087 |
89 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46914087 |
90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46744808 |
91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45818212 |
92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.44178013 |
93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43980738 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43223765 |
95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42664094 |
96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42398749 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41930951 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41599408 |
99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41423313 |
100 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38570122 |
101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38167067 |
102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38026259 |
103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35041072 |
104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34790633 |
105 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34491458 |
106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34265877 |
107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34231539 |
108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31514246 |
109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30471133 |
110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29255846 |
111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29159232 |
112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29116390 |
113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28422100 |
114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27411474 |
115 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.27399707 |
116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26819239 |
117 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.25922728 |
118 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25780579 |
119 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.22637142 |
120 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22216857 |
121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22098521 |
122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21631928 |
123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21409626 |
124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21301940 |
125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21039026 |
126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20188658 |
127 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.19751385 |
128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17759212 |
129 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15881136 |
130 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14823699 |
131 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.11670268 |
132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10312447 |
133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10280542 |
134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09920836 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09516101 |
136 | MYC_22102868_ChIP-Seq_BL_Human | 1.06611369 |
137 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06281484 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05795113 |
139 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04685138 |
140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04564868 |
141 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04464962 |
142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03804004 |
143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03611302 |
144 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02752515 |
145 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02573431 |
146 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02435629 |
147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02218876 |
148 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02090681 |
149 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01920492 |
150 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01782748 |
151 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01340125 |
152 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01200720 |
153 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.00180630 |
154 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99798222 |
155 | P300_27268052_Chip-Seq_Bcells_Human | 0.98662985 |
156 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98642680 |
157 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98558695 |
158 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98512158 |
159 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98208415 |
160 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98182794 |
161 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97701462 |
162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97410740 |
163 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97377754 |
164 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96878673 |
165 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96053460 |
166 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95094936 |
167 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95024875 |
168 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94993803 |
169 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94828481 |
170 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94431918 |
171 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92715244 |
172 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92345923 |
173 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.91880314 |
174 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.91237386 |
175 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89822414 |
176 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88804042 |
177 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86330706 |
178 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86077721 |
179 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85537855 |
180 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84801678 |
181 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.83728356 |
182 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83347193 |
183 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83057486 |
184 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81509332 |
185 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81194320 |
186 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.81171493 |
187 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80402330 |
188 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.80091953 |
189 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78574029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005499_abnormal_olfactory_system | 4.38758374 |
2 | MP0005394_taste/olfaction_phenotype | 4.38758374 |
3 | MP0004858_abnormal_nervous_system | 4.30824269 |
4 | MP0006292_abnormal_olfactory_placode | 3.88973550 |
5 | MP0003436_decreased_susceptibility_to | 3.83884303 |
6 | MP0004859_abnormal_synaptic_plasticity | 3.72057075 |
7 | MP0002254_reproductive_system_inflammat | 3.61542605 |
8 | MP0004264_abnormal_extraembryonic_tissu | 3.53641881 |
9 | MP0003303_peritoneal_inflammation | 3.44916027 |
10 | MP0001835_abnormal_antigen_presentation | 3.33654291 |
11 | MP0003011_delayed_dark_adaptation | 3.26326071 |
12 | MP0003122_maternal_imprinting | 3.17844135 |
13 | MP0003724_increased_susceptibility_to | 3.02122923 |
14 | MP0003763_abnormal_thymus_physiology | 2.94144368 |
15 | MP0003890_abnormal_embryonic-extraembry | 2.86526600 |
16 | MP0002132_abnormal_respiratory_system | 2.74948132 |
17 | MP0004270_analgesia | 2.68922570 |
18 | MP0001800_abnormal_humoral_immune | 2.66417729 |
19 | MP0002396_abnormal_hematopoietic_system | 2.58047480 |
20 | MP0002419_abnormal_innate_immunity | 2.56892450 |
21 | MP0005025_abnormal_response_to | 2.56573473 |
22 | MP0005075_abnormal_melanosome_morpholog | 2.46732046 |
23 | MP0005464_abnormal_platelet_physiology | 2.42352001 |
24 | MP0002420_abnormal_adaptive_immunity | 2.36094667 |
25 | MP0001819_abnormal_immune_cell | 2.33244216 |
26 | MP0005000_abnormal_immune_tolerance | 2.31882741 |
27 | MP0001790_abnormal_immune_system | 2.31640077 |
28 | MP0005387_immune_system_phenotype | 2.31640077 |
29 | MP0010155_abnormal_intestine_physiology | 2.29888477 |
30 | MP0002723_abnormal_immune_serum | 2.28117623 |
31 | MP0002332_abnormal_exercise_endurance | 2.25078776 |
32 | MP0003635_abnormal_synaptic_transmissio | 2.22418851 |
33 | MP0002452_abnormal_antigen_presenting | 2.20157722 |
34 | MP0002653_abnormal_ependyma_morphology | 2.19621703 |
35 | MP0008961_abnormal_basal_metabolism | 2.19502369 |
36 | MP0003121_genomic_imprinting | 2.19011465 |
37 | MP0003183_abnormal_peptide_metabolism | 2.15827692 |
38 | MP0003172_abnormal_lysosome_physiology | 2.14384080 |
39 | MP0002398_abnormal_bone_marrow | 2.13735123 |
40 | MP0003866_abnormal_defecation | 2.12920778 |
41 | MP0009333_abnormal_splenocyte_physiolog | 2.10276312 |
42 | MP0000465_gastrointestinal_hemorrhage | 2.08667269 |
43 | MP0003300_gastrointestinal_ulcer | 2.07886514 |
44 | MP0008260_abnormal_autophagy | 2.07661002 |
45 | MP0008789_abnormal_olfactory_epithelium | 2.06472052 |
46 | MP0000685_abnormal_immune_system | 2.04572489 |
47 | MP0006035_abnormal_mitochondrial_morpho | 1.99312207 |
48 | MP0009278_abnormal_bone_marrow | 1.97263905 |
49 | MP0005058_abnormal_lysosome_morphology | 1.95439119 |
50 | MP0003880_abnormal_central_pattern | 1.95241885 |
51 | MP0003787_abnormal_imprinting | 1.95013124 |
52 | MP0005671_abnormal_response_to | 1.94473280 |
53 | MP0002063_abnormal_learning/memory/cond | 1.93649206 |
54 | MP0005451_abnormal_body_composition | 1.87738683 |
55 | MP0002572_abnormal_emotion/affect_behav | 1.87727856 |
56 | MP0000716_abnormal_immune_system | 1.87031643 |
57 | MP0002405_respiratory_system_inflammati | 1.84521411 |
58 | MP0005397_hematopoietic_system_phenotyp | 1.80562678 |
59 | MP0001545_abnormal_hematopoietic_system | 1.80562678 |
60 | MP0001984_abnormal_olfaction | 1.80407209 |
61 | MP0009046_muscle_twitch | 1.80194891 |
62 | MP0001486_abnormal_startle_reflex | 1.79988751 |
63 | MP0002722_abnormal_immune_system | 1.79261592 |
64 | MP0000703_abnormal_thymus_morphology | 1.78501967 |
65 | MP0009785_altered_susceptibility_to | 1.78008741 |
66 | MP0004947_skin_inflammation | 1.77345021 |
67 | MP0008057_abnormal_DNA_replication | 1.73132476 |
68 | MP0003938_abnormal_ear_development | 1.72536155 |
69 | MP0003191_abnormal_cellular_cholesterol | 1.72323189 |
70 | MP0002064_seizures | 1.67386255 |
71 | MP0000689_abnormal_spleen_morphology | 1.67375707 |
72 | MP0002429_abnormal_blood_cell | 1.62221895 |
73 | MP0008004_abnormal_stomach_pH | 1.61106292 |
74 | MP0001533_abnormal_skeleton_physiology | 1.58876316 |
75 | MP0005257_abnormal_intraocular_pressure | 1.58466863 |
76 | MP0002148_abnormal_hypersensitivity_rea | 1.57573411 |
77 | MP0009745_abnormal_behavioral_response | 1.56899498 |
78 | MP0002009_preneoplasia | 1.55387157 |
79 | MP0003123_paternal_imprinting | 1.53061078 |
80 | MP0002734_abnormal_mechanical_nocicepti | 1.52705562 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 1.51752164 |
82 | MP0001873_stomach_inflammation | 1.51152757 |
83 | MP0001501_abnormal_sleep_pattern | 1.48647331 |
84 | MP0000858_altered_metastatic_potential | 1.48434140 |
85 | MP0000678_abnormal_parathyroid_gland | 1.47902608 |
86 | MP0001845_abnormal_inflammatory_respons | 1.47237938 |
87 | MP0003828_pulmonary_edema | 1.45238546 |
88 | MP0002127_abnormal_cardiovascular_syste | 1.42549293 |
89 | MP0002909_abnormal_adrenal_gland | 1.42486641 |
90 | MP0002272_abnormal_nervous_system | 1.37737644 |
91 | MP0000490_abnormal_crypts_of | 1.37491942 |
92 | MP0004043_abnormal_pH_regulation | 1.37323355 |
93 | MP0004808_abnormal_hematopoietic_stem | 1.30549276 |
94 | MP0003705_abnormal_hypodermis_morpholog | 1.28169692 |
95 | MP0002184_abnormal_innervation | 1.26446982 |
96 | MP0004957_abnormal_blastocyst_morpholog | 1.25657799 |
97 | MP0008872_abnormal_physiological_respon | 1.24132563 |
98 | MP0008469_abnormal_protein_level | 1.22716279 |
99 | MP0003283_abnormal_digestive_organ | 1.22294231 |
100 | MP0001851_eye_inflammation | 1.19729960 |
101 | MP0002233_abnormal_nose_morphology | 1.14097223 |
102 | MP0002166_altered_tumor_susceptibility | 1.13904159 |
103 | MP0005076_abnormal_cell_differentiation | 1.13285978 |
104 | MP0002277_abnormal_respiratory_mucosa | 1.12738069 |
105 | MP0004381_abnormal_hair_follicle | 1.11870518 |
106 | MP0001663_abnormal_digestive_system | 1.11785510 |
107 | MP0000955_abnormal_spinal_cord | 1.11470332 |
108 | MP0003137_abnormal_impulse_conducting | 1.09834281 |
109 | MP0002733_abnormal_thermal_nociception | 1.08846974 |
110 | MP0001293_anophthalmia | 1.04811189 |
111 | MP0000762_abnormal_tongue_morphology | 1.04196768 |
112 | MP0001672_abnormal_embryogenesis/_devel | 1.03255315 |
113 | MP0005380_embryogenesis_phenotype | 1.03255315 |
114 | MP0002998_abnormal_bone_remodeling | 1.00747868 |
115 | MP0010352_gastrointestinal_tract_polyps | 1.00322507 |
116 | MP0002933_joint_inflammation | 0.99734201 |
117 | MP0002932_abnormal_joint_morphology | 0.98922130 |
118 | MP0002822_catalepsy | 0.97670452 |
119 | MP0001970_abnormal_pain_threshold | 0.96490676 |
120 | MP0001853_heart_inflammation | 0.96264531 |
121 | MP0008770_decreased_survivor_rate | 0.95930773 |
122 | MP0001348_abnormal_lacrimal_gland | 0.94902801 |
123 | MP0004185_abnormal_adipocyte_glucose | 0.94853200 |
124 | MP0002088_abnormal_embryonic_growth/wei | 0.94399572 |
125 | MP0001849_ear_inflammation | 0.93990553 |
126 | MP0003984_embryonic_growth_retardation | 0.93759725 |
127 | MP0005360_urolithiasis | 0.93012204 |
128 | MP0001968_abnormal_touch/_nociception | 0.92890554 |
129 | MP0005266_abnormal_metabolism | 0.91531428 |
130 | MP0005166_decreased_susceptibility_to | 0.91360460 |
131 | MP0000778_abnormal_nervous_system | 0.91224350 |
132 | MP0004811_abnormal_neuron_physiology | 0.89876689 |
133 | MP0002882_abnormal_neuron_morphology | 0.89847039 |
134 | MP0002557_abnormal_social/conspecific_i | 0.87560597 |
135 | MP0001440_abnormal_grooming_behavior | 0.87466749 |
136 | MP0002751_abnormal_autonomic_nervous | 0.87009935 |
137 | MP0002067_abnormal_sensory_capabilities | 0.86832329 |
138 | MP0004883_abnormal_blood_vessel | 0.86556238 |
139 | MP0003119_abnormal_digestive_system | 0.86552081 |
140 | MP0002752_abnormal_somatic_nervous | 0.86086226 |
141 | MP0006082_CNS_inflammation | 0.85419534 |
142 | MP0002114_abnormal_axial_skeleton | 0.84094355 |
143 | MP0000015_abnormal_ear_pigmentation | 0.83964421 |
144 | MP0002092_abnormal_eye_morphology | 0.83134704 |
145 | MP0010234_abnormal_vibrissa_follicle | 0.82869279 |
146 | MP0000049_abnormal_middle_ear | 0.82472052 |
147 | MP0003091_abnormal_cell_migration | 0.82383552 |
148 | MP0008874_decreased_physiological_sensi | 0.81872842 |
149 | MP0005083_abnormal_biliary_tract | 0.79771932 |
150 | MP0001765_abnormal_ion_homeostasis | 0.79415131 |
151 | MP0000249_abnormal_blood_vessel | 0.79410880 |
152 | MP0003861_abnormal_nervous_system | 0.78561826 |
153 | MP0004142_abnormal_muscle_tone | 0.77261994 |
154 | MP0005623_abnormal_meninges_morphology | 0.76531516 |
155 | MP0000681_abnormal_thyroid_gland | 0.76197526 |
156 | MP0005666_abnormal_adipose_tissue | 0.74974968 |
157 | MP0002019_abnormal_tumor_incidence | 0.74759365 |
158 | MP0004085_abnormal_heartbeat | 0.73770038 |
159 | MP0005390_skeleton_phenotype | 0.73696737 |
160 | MP0005409_darkened_coat_color | 0.73198325 |
161 | MP0004133_heterotaxia | 0.72742359 |
162 | MP0009763_increased_sensitivity_to | 0.71840409 |
163 | MP0005381_digestive/alimentary_phenotyp | 0.70215927 |
164 | MP0003045_fibrosis | 0.69775947 |
165 | MP0000477_abnormal_intestine_morphology | 0.68905882 |
166 | MP0002081_perinatal_lethality | 0.68276541 |
167 | MP0005164_abnormal_response_to | 0.67867648 |
168 | MP0000631_abnormal_neuroendocrine_gland | 0.67536285 |
169 | MP0000350_abnormal_cell_proliferation | 0.67294501 |
170 | MP0001986_abnormal_taste_sensitivity | 0.67260397 |
171 | MP0002970_abnormal_white_adipose | 0.67258410 |
172 | MP0002152_abnormal_brain_morphology | 0.65756779 |
173 | MP0009840_abnormal_foam_cell | 0.65659620 |
174 | MP0005391_vision/eye_phenotype | 0.65598496 |
175 | MP0002086_abnormal_extraembryonic_tissu | 0.65269158 |
176 | MP0002249_abnormal_larynx_morphology | 0.64947525 |
177 | MP0002085_abnormal_embryonic_tissue | 0.64714792 |
178 | MP0003453_abnormal_keratinocyte_physiol | 0.63525833 |
179 | MP0003935_abnormal_craniofacial_develop | 0.63410794 |
180 | MP0005310_abnormal_salivary_gland | 0.62222612 |
181 | MP0002229_neurodegeneration | 0.62034411 |
182 | MP0003755_abnormal_palate_morphology | 0.60953908 |
183 | MP0001664_abnormal_digestion | 0.60346094 |
184 | MP0005621_abnormal_cell_physiology | 0.60023418 |
185 | MP0002066_abnormal_motor_capabilities/c | 0.59705637 |
186 | MP0003448_altered_tumor_morphology | 0.59182646 |
187 | MP0005253_abnormal_eye_physiology | 0.59163389 |
188 | MP0003795_abnormal_bone_structure | 0.57724914 |
189 | MP0005410_abnormal_fertilization | 0.57476633 |
190 | MP0009764_decreased_sensitivity_to | 0.57399930 |
191 | MP0000470_abnormal_stomach_morphology | 0.56111686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 7.11466658 |
2 | Hypochromic microcytic anemia (HP:0004840) | 6.37123699 |
3 | Abnormality of the lower motor neuron (HP:0002366) | 5.68251191 |
4 | Eczematoid dermatitis (HP:0000976) | 5.33000524 |
5 | Hepatoblastoma (HP:0002884) | 5.24811072 |
6 | Recurrent abscess formation (HP:0002722) | 4.87383517 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.80381757 |
8 | Nasal polyposis (HP:0100582) | 4.46560462 |
9 | Hyperventilation (HP:0002883) | 4.35208500 |
10 | Multiple enchondromatosis (HP:0005701) | 4.14808250 |
11 | Rib fusion (HP:0000902) | 4.12331741 |
12 | Myositis (HP:0100614) | 3.98538574 |
13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.97982953 |
14 | Abnormality of macrophages (HP:0004311) | 3.87235691 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 3.86339351 |
16 | Gastrointestinal infarctions (HP:0005244) | 3.74445341 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70277362 |
18 | Obstructive lung disease (HP:0006536) | 3.70277362 |
19 | Prolonged bleeding time (HP:0003010) | 3.69691769 |
20 | Febrile seizures (HP:0002373) | 3.64575784 |
21 | Ependymoma (HP:0002888) | 3.59696787 |
22 | Testicular atrophy (HP:0000029) | 3.59113814 |
23 | Amyotrophic lateral sclerosis (HP:0007354) | 3.57144077 |
24 | Amblyopia (HP:0000646) | 3.44015341 |
25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.43808165 |
26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.40248252 |
27 | Neoplasm of striated muscle (HP:0009728) | 3.37952516 |
28 | Recurrent fungal infections (HP:0002841) | 3.35676062 |
29 | Meningitis (HP:0001287) | 3.31127062 |
30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.29496575 |
31 | Epileptic encephalopathy (HP:0200134) | 3.24232251 |
32 | Bifid tongue (HP:0010297) | 3.23071285 |
33 | Increased IgE level (HP:0003212) | 3.20606095 |
34 | Horizontal nystagmus (HP:0000666) | 3.20404252 |
35 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.16899154 |
36 | Generalized hypotonia (HP:0001290) | 3.15139167 |
37 | Recurrent skin infections (HP:0001581) | 3.14895577 |
38 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.11532061 |
39 | Absent/shortened dynein arms (HP:0200106) | 3.11532061 |
40 | Cellulitis (HP:0100658) | 3.11070274 |
41 | Pustule (HP:0200039) | 3.10705850 |
42 | Stomatitis (HP:0010280) | 3.06402047 |
43 | Gastrointestinal inflammation (HP:0004386) | 3.05628570 |
44 | Spontaneous hematomas (HP:0007420) | 3.05191190 |
45 | Petechiae (HP:0000967) | 3.03138482 |
46 | Recurrent viral infections (HP:0004429) | 3.00838165 |
47 | Panhypogammaglobulinemia (HP:0003139) | 2.98418325 |
48 | Ragged-red muscle fibers (HP:0003200) | 2.98337573 |
49 | Rhabdomyosarcoma (HP:0002859) | 2.98013642 |
50 | Inflammation of the large intestine (HP:0002037) | 2.95252354 |
51 | Embryonal renal neoplasm (HP:0011794) | 2.93539731 |
52 | Focal seizures (HP:0007359) | 2.92734559 |
53 | Atonic seizures (HP:0010819) | 2.91392855 |
54 | Colitis (HP:0002583) | 2.84529669 |
55 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.83379953 |
56 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.83379953 |
57 | Orchitis (HP:0100796) | 2.82453523 |
58 | Mediastinal lymphadenopathy (HP:0100721) | 2.81047657 |
59 | Gingivitis (HP:0000230) | 2.80874846 |
60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80531471 |
61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80531471 |
62 | Agammaglobulinemia (HP:0004432) | 2.79973875 |
63 | Abnormality of the astrocytes (HP:0100707) | 2.79906912 |
64 | Astrocytoma (HP:0009592) | 2.79906912 |
65 | Abnormality of the fingertips (HP:0001211) | 2.79273764 |
66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.77945826 |
67 | Hypoplasia of the fovea (HP:0007750) | 2.77945826 |
68 | Epistaxis (HP:0000421) | 2.77145821 |
69 | Encephalitis (HP:0002383) | 2.74915887 |
70 | Resting tremor (HP:0002322) | 2.74697417 |
71 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.73615788 |
72 | Neoplasm of the heart (HP:0100544) | 2.69113922 |
73 | Chronic otitis media (HP:0000389) | 2.68478651 |
74 | Sensory axonal neuropathy (HP:0003390) | 2.67190962 |
75 | Purpura (HP:0000979) | 2.66756316 |
76 | Recurrent sinusitis (HP:0011108) | 2.65136658 |
77 | Chest pain (HP:0100749) | 2.64997953 |
78 | Dialeptic seizures (HP:0011146) | 2.62933866 |
79 | Vasculitis (HP:0002633) | 2.61921310 |
80 | Abnormal ciliary motility (HP:0012262) | 2.61724001 |
81 | Rectal fistula (HP:0100590) | 2.59754281 |
82 | Rectovaginal fistula (HP:0000143) | 2.59754281 |
83 | Tetraplegia (HP:0002445) | 2.56716558 |
84 | Partial duplication of thumb phalanx (HP:0009944) | 2.55451305 |
85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51707053 |
86 | Anomalous pulmonary venous return (HP:0010772) | 2.50311339 |
87 | Retrobulbar optic neuritis (HP:0100654) | 2.48929016 |
88 | Optic neuritis (HP:0100653) | 2.48929016 |
89 | Abnormality of the salivary glands (HP:0010286) | 2.48709865 |
90 | Dyschromatopsia (HP:0007641) | 2.48693458 |
91 | Bronchiectasis (HP:0002110) | 2.48570878 |
92 | Focal motor seizures (HP:0011153) | 2.48339353 |
93 | Osteomyelitis (HP:0002754) | 2.48202737 |
94 | Abnormality of T cell physiology (HP:0011840) | 2.46645490 |
95 | Granulocytopenia (HP:0001913) | 2.44721156 |
96 | Preauricular pit (HP:0004467) | 2.43161081 |
97 | Periauricular skin pits (HP:0100277) | 2.43161081 |
98 | Hemiparesis (HP:0001269) | 2.41774597 |
99 | Intestinal fistula (HP:0100819) | 2.41294464 |
100 | Abnormality of T cells (HP:0002843) | 2.37038022 |
101 | Hypochromic anemia (HP:0001931) | 2.36883382 |
102 | Amyloidosis (HP:0011034) | 2.36369694 |
103 | Fused cervical vertebrae (HP:0002949) | 2.35544673 |
104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33601819 |
105 | Urticaria (HP:0001025) | 2.33247709 |
106 | Rhinitis (HP:0012384) | 2.31022620 |
107 | Polygenic inheritance (HP:0010982) | 2.30014469 |
108 | Preauricular skin tag (HP:0000384) | 2.29423758 |
109 | Recurrent otitis media (HP:0000403) | 2.28745113 |
110 | Hypertensive crisis (HP:0100735) | 2.28745011 |
111 | Polycythemia (HP:0001901) | 2.27504143 |
112 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.27194847 |
113 | Abnormality of chromosome segregation (HP:0002916) | 2.27027401 |
114 | Vaginal fistula (HP:0004320) | 2.25428493 |
115 | Malnutrition (HP:0004395) | 2.24923078 |
116 | Short humerus (HP:0005792) | 2.22323274 |
117 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.21815269 |
118 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.21600586 |
119 | Renal duplication (HP:0000075) | 2.21416264 |
120 | Hemorrhage of the eye (HP:0011885) | 2.20924917 |
121 | Gingival bleeding (HP:0000225) | 2.20552511 |
122 | Myokymia (HP:0002411) | 2.20077950 |
123 | Abnormality of the fovea (HP:0000493) | 2.19587405 |
124 | Seborrheic dermatitis (HP:0001051) | 2.15827552 |
125 | Recurrent bronchitis (HP:0002837) | 2.15557854 |
126 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.15545552 |
127 | Partial duplication of the phalanx of hand (HP:0009999) | 2.14645335 |
128 | Increased serum ferritin (HP:0003281) | 2.14364431 |
129 | Viral hepatitis (HP:0006562) | 2.12861455 |
130 | Generalized tonic-clonic seizures (HP:0002069) | 2.12639399 |
131 | Thrombocytosis (HP:0001894) | 2.12153728 |
132 | Status epilepticus (HP:0002133) | 2.12018641 |
133 | Papilloma (HP:0012740) | 2.11676834 |
134 | Verrucae (HP:0200043) | 2.11676834 |
135 | Nasolacrimal duct obstruction (HP:0000579) | 2.11061458 |
136 | Abnormality of the pubic bones (HP:0003172) | 2.10347480 |
137 | Atelectasis (HP:0100750) | 2.09864029 |
138 | Skin tags (HP:0010609) | 2.08364239 |
139 | Abnormal platelet function (HP:0011869) | 2.08360940 |
140 | Impaired platelet aggregation (HP:0003540) | 2.08360940 |
141 | Abnormal lung lobation (HP:0002101) | 2.08316199 |
142 | Lymphopenia (HP:0001888) | 2.05962822 |
143 | Abnormality of the pulmonary veins (HP:0011718) | 2.04722137 |
144 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.04180585 |
145 | Trismus (HP:0000211) | 2.03491416 |
146 | Episodic fever (HP:0001954) | 2.02425046 |
147 | Arterial thrombosis (HP:0004420) | 2.02371754 |
148 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02147366 |
149 | Villous atrophy (HP:0011473) | 2.02147366 |
150 | Absence seizures (HP:0002121) | 2.01912073 |
151 | Large earlobe (HP:0009748) | 2.01892511 |
152 | T lymphocytopenia (HP:0005403) | 2.01572016 |
153 | Difficulty running (HP:0009046) | 2.01369064 |
154 | Bronchitis (HP:0012387) | 2.00485633 |
155 | Shawl scrotum (HP:0000049) | 1.99433762 |
156 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98253560 |
157 | Hand muscle atrophy (HP:0009130) | 1.98144922 |
158 | Abnormal cartilage morphology (HP:0002763) | 1.97430069 |
159 | Progressive external ophthalmoplegia (HP:0000590) | 1.97137196 |
160 | Glioma (HP:0009733) | 1.95710461 |
161 | Hypopigmentation of the fundus (HP:0007894) | 1.95679541 |
162 | Visual hallucinations (HP:0002367) | 1.94937321 |
163 | Slow saccadic eye movements (HP:0000514) | 1.93999857 |
164 | Hemoptysis (HP:0002105) | 1.93973047 |
165 | Sepsis (HP:0100806) | 1.93722141 |
166 | Abnormality of the corticospinal tract (HP:0002492) | 1.92686438 |
167 | Supernumerary spleens (HP:0009799) | 1.92667467 |
168 | Achilles tendon contracture (HP:0001771) | 1.91999920 |
169 | Chronic sinusitis (HP:0011109) | 1.91900742 |
170 | Abnormality of the musculature of the hand (HP:0001421) | 1.91457314 |
171 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91099940 |
172 | Pendular nystagmus (HP:0012043) | 1.90916097 |
173 | Abnormality of T cell number (HP:0011839) | 1.90883367 |
174 | Supernumerary nipples (HP:0002558) | 1.90689238 |
175 | Spastic tetraparesis (HP:0001285) | 1.90606065 |
176 | Skin pits (HP:0100276) | 1.90404600 |
177 | Abnormality of iron homeostasis (HP:0011031) | 1.90270995 |
178 | Metaphyseal cupping (HP:0003021) | 1.89827853 |
179 | Leukocytosis (HP:0001974) | 1.88477560 |
180 | Progressive muscle weakness (HP:0003323) | 1.88030039 |
181 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.87253174 |
182 | Neuroectodermal neoplasm (HP:0030061) | 1.87108531 |
183 | Neuroepithelial neoplasm (HP:0030063) | 1.87108531 |
184 | Nervous tissue neoplasm (HP:0030060) | 1.87108531 |
185 | Facial cleft (HP:0002006) | 1.86806541 |
186 | Fatigue (HP:0012378) | 1.85494905 |
187 | Multifactorial inheritance (HP:0001426) | 1.85253054 |
188 | Open mouth (HP:0000194) | 1.85043658 |
189 | Gastrointestinal stroma tumor (HP:0100723) | 1.84262457 |
190 | Skin ulcer (HP:0200042) | 1.83228619 |
191 | Dysphonia (HP:0001618) | 1.82662834 |
192 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.82533140 |
193 | Hypergammaglobulinemia (HP:0010702) | 1.82198932 |
194 | Pulmonary infiltrates (HP:0002113) | 1.81649628 |
195 | Tongue fasciculations (HP:0001308) | 1.81265189 |
196 | Tented upper lip vermilion (HP:0010804) | 1.81165207 |
197 | Drooling (HP:0002307) | 1.79710128 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 6.45063640 |
2 | GRK5 | 5.41837347 |
3 | GRK6 | 4.16505511 |
4 | MAP4K1 | 3.86018962 |
5 | ERN1 | 3.61147701 |
6 | TYRO3 | 2.94110020 |
7 | GRK1 | 2.93540420 |
8 | TRIB3 | 2.93085052 |
9 | MAP3K9 | 2.75469916 |
10 | ADRBK2 | 2.65143390 |
11 | MAP2K3 | 2.45731613 |
12 | TYK2 | 2.44867809 |
13 | CSF1R | 2.37953618 |
14 | FES | 2.34510435 |
15 | EPHA4 | 2.30222095 |
16 | NTRK1 | 2.16031495 |
17 | MAPK7 | 2.15086170 |
18 | MATK | 2.14092981 |
19 | ZAP70 | 2.07472449 |
20 | SMG1 | 2.07427053 |
21 | MAP2K4 | 2.05894022 |
22 | BTK | 2.01580833 |
23 | GRK7 | 1.99808853 |
24 | BLK | 1.99418014 |
25 | NTRK3 | 1.94835308 |
26 | MOS | 1.93593903 |
27 | MAPK15 | 1.93500815 |
28 | WNK1 | 1.91298746 |
29 | DAPK2 | 1.66499831 |
30 | IRAK4 | 1.65659374 |
31 | TGFBR2 | 1.61957896 |
32 | ARAF | 1.58249623 |
33 | SIK3 | 1.56796998 |
34 | TTK | 1.48233518 |
35 | CAMK4 | 1.47427036 |
36 | HCK | 1.45646805 |
37 | TBK1 | 1.43904379 |
38 | MAP3K14 | 1.35704326 |
39 | MARK2 | 1.35098048 |
40 | EPHB1 | 1.35040434 |
41 | SIK2 | 1.30815635 |
42 | SYK | 1.29795360 |
43 | JAK3 | 1.28242244 |
44 | PRPF4B | 1.27651893 |
45 | MAP3K3 | 1.24589752 |
46 | MAP3K1 | 1.24200590 |
47 | EEF2K | 1.22227093 |
48 | MAP3K11 | 1.21641302 |
49 | TXK | 1.16686875 |
50 | NME2 | 1.16079451 |
51 | ITK | 1.14946898 |
52 | STK10 | 1.13332398 |
53 | LRRK2 | 1.10584452 |
54 | TEC | 1.10569937 |
55 | PTK6 | 1.10128678 |
56 | MAP3K4 | 1.07045220 |
57 | HIPK2 | 1.06985589 |
58 | MAP3K7 | 1.06205881 |
59 | DAPK1 | 1.02493597 |
60 | AKT3 | 1.01507247 |
61 | LYN | 1.00963283 |
62 | LCK | 0.99834002 |
63 | NTRK2 | 0.95036742 |
64 | JAK2 | 0.94754366 |
65 | CASK | 0.94407596 |
66 | KIT | 0.93929701 |
67 | PDPK1 | 0.93565907 |
68 | PAK6 | 0.92296519 |
69 | IKBKE | 0.92008975 |
70 | PKN2 | 0.91937826 |
71 | MAP3K13 | 0.90883761 |
72 | PRKG2 | 0.90759566 |
73 | TAOK2 | 0.90659886 |
74 | MAP3K2 | 0.89603678 |
75 | ADRBK1 | 0.89234798 |
76 | JAK1 | 0.88566537 |
77 | BMPR2 | 0.86510549 |
78 | RIPK1 | 0.85124252 |
79 | MST1R | 0.84809896 |
80 | KSR2 | 0.84478895 |
81 | STK38 | 0.84104317 |
82 | TESK2 | 0.83739212 |
83 | ALK | 0.83408947 |
84 | RIPK4 | 0.82804109 |
85 | MAPK12 | 0.82707037 |
86 | MARK3 | 0.82404080 |
87 | PRKD3 | 0.81983355 |
88 | PRKCG | 0.81576320 |
89 | FGFR3 | 0.80856700 |
90 | CDK4 | 0.79284549 |
91 | MAP3K10 | 0.76013724 |
92 | MINK1 | 0.75502376 |
93 | MAP2K6 | 0.73204272 |
94 | SIK1 | 0.72468062 |
95 | MAPK11 | 0.71721070 |
96 | MAP3K6 | 0.69247350 |
97 | RET | 0.67430547 |
98 | CDK6 | 0.64361640 |
99 | CDK5 | 0.62906849 |
100 | TAOK3 | 0.62600803 |
101 | YES1 | 0.62055069 |
102 | FGFR4 | 0.59748014 |
103 | MAP3K8 | 0.59433611 |
104 | PRKCH | 0.59227153 |
105 | MAP2K2 | 0.58129630 |
106 | CHEK2 | 0.58120194 |
107 | DYRK1A | 0.57924815 |
108 | MAP2K7 | 0.57717754 |
109 | PRKCQ | 0.55077432 |
110 | RPS6KA4 | 0.54624768 |
111 | TRPM7 | 0.54095253 |
112 | CDK15 | 0.53728435 |
113 | KDR | 0.53194219 |
114 | PASK | 0.52488329 |
115 | AKT2 | 0.52303701 |
116 | BRD4 | 0.52004615 |
117 | CDK18 | 0.51852958 |
118 | TNK2 | 0.50800056 |
119 | CDK7 | 0.50523565 |
120 | PRKD2 | 0.49855733 |
121 | CSK | 0.49343717 |
122 | IKBKB | 0.48991718 |
123 | PDGFRA | 0.48461917 |
124 | PAK3 | 0.47429492 |
125 | FYN | 0.46757209 |
126 | RPS6KC1 | 0.46231890 |
127 | RPS6KL1 | 0.46231890 |
128 | CDK11A | 0.45213677 |
129 | PTK2B | 0.44290858 |
130 | DYRK1B | 0.43747605 |
131 | TAOK1 | 0.43649531 |
132 | MAPK10 | 0.42566223 |
133 | KSR1 | 0.42108146 |
134 | PAK4 | 0.41765613 |
135 | PLK1 | 0.41353835 |
136 | CDK14 | 0.40265627 |
137 | CAMK1 | 0.40080215 |
138 | PDK1 | 0.39500368 |
139 | CAMKK1 | 0.38936228 |
140 | PRKCI | 0.37828951 |
141 | EPHA2 | 0.37451606 |
142 | LATS2 | 0.37385378 |
143 | MAPKAPK2 | 0.36703608 |
144 | CHEK1 | 0.36315890 |
145 | RAF1 | 0.35710340 |
146 | PIM1 | 0.35673236 |
147 | UHMK1 | 0.35130081 |
148 | CDK19 | 0.34662012 |
149 | ICK | 0.34090913 |
150 | PLK2 | 0.32181201 |
151 | FGR | 0.31554678 |
152 | DDR2 | 0.30190139 |
153 | CSNK1E | 0.28104204 |
154 | BMX | 0.27032394 |
155 | PTK2 | 0.26867575 |
156 | MARK1 | 0.26634286 |
157 | RPS6KA3 | 0.26143067 |
158 | PHKG1 | 0.23303266 |
159 | PHKG2 | 0.23303266 |
160 | PRKCD | 0.22649838 |
161 | GSK3B | 0.22271883 |
162 | STK11 | 0.22094061 |
163 | CDC42BPA | 0.21795843 |
164 | CDK2 | 0.21318408 |
165 | BRAF | 0.21005811 |
166 | IGF1R | 0.20289231 |
167 | PRKACA | 0.18983992 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.50119622 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.60763676 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.95403468 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75845262 |
5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.45905703 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45686449 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39253129 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36540145 |
9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.32154645 |
10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28722816 |
11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.26274341 |
12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.21885437 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17339741 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14915602 |
15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.13828418 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 2.05063491 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02868208 |
18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01581114 |
19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97725843 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.96241248 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95281691 |
22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.81389031 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77181322 |
24 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.74161501 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73418689 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70702402 |
27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.68558919 |
28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66637405 |
29 | Morphine addiction_Homo sapiens_hsa05032 | 1.66185810 |
30 | Salivary secretion_Homo sapiens_hsa04970 | 1.63191709 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58492037 |
32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56947374 |
33 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.54761377 |
34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53685958 |
35 | Tuberculosis_Homo sapiens_hsa05152 | 1.53095383 |
36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.52975487 |
37 | Long-term depression_Homo sapiens_hsa04730 | 1.52693882 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.51353744 |
39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50658346 |
40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46624318 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44917264 |
42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43973618 |
43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.43789910 |
44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42161944 |
45 | Measles_Homo sapiens_hsa05162 | 1.41181794 |
46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40859770 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40339016 |
48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38940796 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.38464499 |
50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37015928 |
51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.32765177 |
52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.32152332 |
53 | Asthma_Homo sapiens_hsa05310 | 1.31817120 |
54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31036662 |
55 | Platelet activation_Homo sapiens_hsa04611 | 1.29490113 |
56 | Insulin secretion_Homo sapiens_hsa04911 | 1.29198092 |
57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.27448459 |
58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26035074 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25398315 |
60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24694019 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.23920455 |
62 | Hepatitis B_Homo sapiens_hsa05161 | 1.23124006 |
63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21055788 |
64 | Renin secretion_Homo sapiens_hsa04924 | 1.19949979 |
65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16928062 |
66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.16530945 |
67 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15082884 |
68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13129219 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.12265482 |
70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11573661 |
71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09608235 |
72 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09498323 |
73 | Malaria_Homo sapiens_hsa05144 | 1.09125424 |
74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.08660571 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06394037 |
76 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06276200 |
77 | Apoptosis_Homo sapiens_hsa04210 | 1.05395806 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04214077 |
79 | Hepatitis C_Homo sapiens_hsa05160 | 1.03428650 |
80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02295897 |
81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00135394 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99150892 |
83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98117131 |
84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97835047 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97797408 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96205730 |
87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94639070 |
88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94153469 |
89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93045207 |
90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91550594 |
91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91491538 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89127898 |
93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87082989 |
94 | Shigellosis_Homo sapiens_hsa05131 | 0.83796243 |
95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83465832 |
96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82902191 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81246109 |
98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81059332 |
99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80937305 |
100 | Glioma_Homo sapiens_hsa05214 | 0.80704608 |
101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80276098 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.79114242 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.78894183 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76593321 |
105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76056223 |
106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75505095 |
107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75447862 |
108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75096555 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74865785 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74731958 |
111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74390492 |
112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74024893 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.72805882 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71988439 |
115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71806152 |
116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70078363 |
117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69892215 |
118 | Axon guidance_Homo sapiens_hsa04360 | 0.68160148 |
119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68027578 |
120 | Pertussis_Homo sapiens_hsa05133 | 0.67540503 |
121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66381542 |
122 | Melanogenesis_Homo sapiens_hsa04916 | 0.64743736 |
123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63071954 |
124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62860085 |
125 | Legionellosis_Homo sapiens_hsa05134 | 0.60265777 |
126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59899584 |
127 | Insulin resistance_Homo sapiens_hsa04931 | 0.59707373 |
128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59573068 |
129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58938393 |
130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58763104 |
131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58539529 |
132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57414698 |
133 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57116333 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57115476 |
135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56680346 |
136 | Salmonella infection_Homo sapiens_hsa05132 | 0.56171757 |
137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55748590 |
138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55524600 |
139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54910627 |
140 | Amoebiasis_Homo sapiens_hsa05146 | 0.53799521 |
141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53243449 |
142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50848175 |
143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50592784 |
144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50058054 |
145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48403752 |
146 | Phototransduction_Homo sapiens_hsa04744 | 0.48173791 |
147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47258642 |
148 | Lysosome_Homo sapiens_hsa04142 | 0.46459428 |
149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46061629 |
150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45584383 |
151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45545322 |
152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45172545 |
153 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43938439 |
154 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43673281 |
155 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43397344 |
156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43181943 |
157 | Prostate cancer_Homo sapiens_hsa05215 | 0.43065489 |
158 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41771737 |
159 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41684723 |
160 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40236115 |
161 | Tight junction_Homo sapiens_hsa04530 | 0.40229353 |
162 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39694972 |
163 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38572632 |
164 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38108490 |
165 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37890995 |
166 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37850966 |
167 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33251991 |
168 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32819577 |
169 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31517844 |